🔎 Trials Near Me

Beranda › Leukemia Mieloid Akut › Connecticut › New Haven

Uji klinis Leukemia Mieloid Akut di New Haven, CT

17 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar New Haven (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Menerima pesertaFase 2
  • Yale University, New Haven
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05564390

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Menerima pesertaFase 1
  • Yale University, New Haven
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06484062

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Yale University, New Haven
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Yale University, New Haven
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Menerima pesertaFase 3
  • Yale University, New Haven
6 Months – 21 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04293562

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Menerima pesertaFase 3
  • Yale University, New Haven
29 Days – 21 Years · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Menerima pesertaFase 3
  • Yale University School of Medicine, New Haven
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Menerima pesertaFase 1
  • Smilow Cancer Hospital at Yale New Haven, New Haven
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06001788

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Menerima pesertaFase 1
  • Yale University, Yale Cancer Center, New Haven
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06656494

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Menerima pesertaStudi observasional
  • Yale New Haven Hospital, New Haven
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Menerima pesertaFase 1
  • Yale New Haven Hospital, New Haven
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT05768932

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Menerima pesertaFase 2/3
  • Yale University, New Haven
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT04256317

Revumenib in Combination With 7+3 + Midostaurin in AML

Menerima pesertaFase 1
  • Yale Cancer Center, New Haven
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Mar 2026 · NCT06313437

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Menerima pesertaFase 1
  • Yale Cancer Center and Smilow Cancer Hospital, New Haven
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT05735184

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Menerima pesertaFase 1/2
  • Yale University, New Haven
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2025 · NCT03850574

Uji klinis Leukemia Mieloid Akut di kota lain

Studi lain di New Haven

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.